TickerFactsScreenerDevelopers

Regen BioPharma Inc (RGBP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2015: -$1.19M2016: -$1.67M2017: -$1.89M2018: -$1.58M2019: -$481.8K2020: $18.6K2021: -$1.13M2022: -$606.9K2023: -$173.9K2024: -$751.5K2025: -$383.6K-$383.6K
2015Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$383.6K+49.0%
2024-$751.5K-332.1%
2023-$173.9K+71.3%
2022-$606.9K+46.3%
2021-$1.13M-6165.6%
2020$18.6K+103.9%
2019-$481.8K+69.5%
2018-$1.58M+16.7%
2017-$1.89M-13.3%
2016-$1.67M-40.2%
2015-$1.19M—